prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist


  1. Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

    Gant, C. M., Laverman, G. D., Vogt, L., Slagman, M. C. J., Heerspink, H. J. L., Waanders, F., Hemmelder, M. H., Navis, G. & Holland Nephrology Study (HONEST) Network 20-Dec-2017 In : Bmc nephrology. 18, 8 p., 370

    Research output: Scientific - peer-reviewArticle

  2. Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension

    Lindhardt, M., Persson, F., Oxlund, C., Jacobsen, I. A., Zürbig, P., Mischak, H., Rossing, P. & Heerspink, H. J. L. 7-Jan-2017 In : Nephrology, Dialysis, Transplantation. 8 p.

    Research output: Scientific - peer-reviewArticle

  3. Renal trials in diabetes need a platform: time for a global approach?

    de Zeeuw, D., Heerspink, H. J. L., Jardine, M. & Perkovic, V. 7-Aug-2017 In : Lancet Diabetes & Endocrinology. 3 p.

    Research output: Scientific - peer-reviewComment/Letter to the editor

  4. Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

    Webb, D. J., Coll, B., Heerspink, H. J. L., Andress, D., Pritchett, Y., Brennan, J. J., Houser, M., Correa-Rotter, R., Kohan, D., Makino, H., Perkovic, V., Remuzzi, G., Tobe, S. W., Toto, R., Busch, R., Pergola, P., Parving, H-H. & de Zeeuw, D. Sep-2017 In : Drugs in R&D. 17, 3, p. 441-448 8 p.

    Research output: Scientific - peer-reviewArticle

View all (201) »

View graph of relations

ID: 208085